Pediatrix Medical Group press release (NYSE:MD): Q2 Non-GAAP EPS of $0.53 beats by $0.11.
Revenue of $468.8M (-7.0% Y/Y) beats by $4.43M.
This decrease reflects the impact of non-same unit activity, primarily practice dispositions, partially offset by growth in same-unit net revenue of 6.4 percent.
Same-unit revenue attributable to patient volume increased by 2.9 percent for the 2025 second quarter as compared to the prior-year period.